Nov 13 (Reuters) - Metsera ( MTSR ) shareholders on
Thursday approved Pfizer's ( PFE ) takeover offer worth up to
$10 billion, allowing the U.S. pharmaceutical giant re-entry
into the lucrative obesity treatment market after a fierce
bidding war with Wegovy-maker Novo Nordisk.